| 861 |
|
Which hospitalisations are ambulatory care-sensitive, to what degree, and how could the rates be reduced? Results of a group consensus study in Germany
|
Sundmacher, L.; Fischbach, D.; Schuettig, W.; Naumann, C.; Augustin, U.; Faisst, C.
|
Elsevier : Elsevier Science Pub. Co.
|
2015
|
|
|
|
| 862 |
|
Who provides GP after-hours care?
|
unknown
|
Elsevier : Elsevier Science Pub. Co.
|
2015
|
|
|
|
| 863 |
|
''Whose data is it anyway?'' The implications of putting small area-level health and social data online
|
Exeter, D. J.; Rodgers, S.; Sabel, C. E.
|
Elsevier : Elsevier Science Pub. Co.
|
2014
|
|
|
|
| 864 |
|
Why and how did Israel adopt activity-based hospital payment? The Procedure-Related Group incremental reform
|
Brammli-Greenberg, Shuli; Waitzberg, Ruth; Perman, Vadim; Gamzu, Ronni
|
Elsevier : Elsevier Science Pub. Co.
|
2016
|
|
|
|
| 865 |
|
Why do generic drugs fail to achieve an adequate market share in Greece? Empirical findings and policy suggestions
|
Balasopoulos, T.; Charonis, A.; Athanasakis, K.; Kyriopoulos, J.; Pavi, E.
|
Elsevier : Elsevier Science Pub. Co.
|
2017
|
|
|
|
| 866 |
|
Why do high-volume hospitals achieve better outcomes? A systematic review about intermediate factors in volume-outcome relationships
|
Mesman, R.; Westert, G. P.; Berden, B. J.; Faber, M. J.
|
Elsevier : Elsevier Science Pub. Co.
|
2015
|
|
|
|
| 867 |
|
Why orphan drug coverage reimbursement decision-making needs patient and public involvement
|
Douglas, C. M.; Wilcox, E.; Burgess, M.; Lynd, L. D.
|
Elsevier : Elsevier Science Pub. Co.
|
2015
|
|
|
|
| 868 |
|
Why we need multi-level health workforce governance: Case studies from nursing and medicine in Germany
|
Kuhlmann, E.; Larsen, C.
|
Elsevier : Elsevier Science Pub. Co.
|
2015
|
|
|
|
| 869 |
|
Willingness and ability to pay for physician services in six Central and Eastern European countries
|
Danyliv, A.; Groot, W.; Gryga, I.; Pavlova, M.
|
Elsevier : Elsevier Science Pub. Co.
|
2014
|
|
|
|
| 870 |
|
Will the next generation of preferential trade and investment agreements undermine prevention of noncommunicable diseases? A prospective policy analysis of the Trans Pacific Partnership Agreement
|
Thow, A. M.; Snowdon, W.; Labonte, R.; Gleeson, D.; Stuckler, D.; Hattersley, L.; Schram, A.; Kay, A.; Friel, S.
|
Elsevier : Elsevier Science Pub. Co.
|
2015
|
|
|
|
| 871 |
|
Working towards integrated community care for older people: Empowering organisational features from a professional perspective
|
Janssen, B. M.; Snoeren, M. W.; Van Regenmortel, T.; Abma, T. A.
|
Elsevier : Elsevier Science Pub. Co.
|
2015
|
|
|
|
| 872 |
|
Workplace exposure to engineered nanomaterials: The Italian path for the definition of occupational health and safety policies
|
Mirabile, M.; Boccuni, F.; Gagliardi, D.; Rondinone, B. M.; Iavicoli, S.
|
Elsevier : Elsevier Science Pub. Co.
|
2014
|
|
|
|
| 873 |
|
World Health Assembly Agendas and trends of international health issues for the last 43 years: Analysis of World Health Assembly Agendas between 1970 and 2012
|
Kitamura, T.; Obara, H.; Takashima, Y.; Takahashi, K.; Inaoka, K.; Nagai, M.; Endo, H.; Jimba, M.; Sugiura, Y.
|
Elsevier ; Elsevier Science Pub. Co.
|
2013
|
|
|
|
| 874 |
|
Worlds apart? An exploration of prescribing and medicine-taking decisions by patients, GPs and local policy makers
|
Solomon, J.; Knapp, P.; Raynor, D. K.; Atkin, K.
|
Elsevier : Elsevier Science Pub. Co.
|
2013
|
|
|
|
| 875 |
|
Would German physicians opt for pay-for-performance programs? A willingness-to-accept experiment in a large general practitioners’ sample
|
Krauth, C.; Liersch, S.; Jensen, S. r.; Amelung, V. E.
|
Elsevier : Elsevier Science Pub. Co.
|
2016
|
|
|
|
기사
(875)
